Compare FormFactor Inc. FormFactor Inc. Common Stock (FORM) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FormFactor Inc. FormFactor Inc. Common Stock vs Nuwellis Inc — how do they compare? FormFactor Inc. FormFactor Inc. Common Stock trades at $139.44 (market cap $10.92B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: FormFactor Inc. FormFactor Inc. Common Stock is far larger — about 4963.6× Nuwellis Inc's market cap, and FormFactor Inc. FormFactor Inc. Common Stock is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold FormFactor Inc. FormFactor Inc. Common Stock for 0 Days and Nuwellis Inc for 26 Days on average.
| FORM | NUWE | |
|---|---|---|
Market Cap | $10.92B | $2.20M |
Volume | 1,056,924 | 121,544 |
Sector | Technology | Health |
52-Week High | $159.93 | $146.65 |
52-Week Low | $38.14 | $0.69 |
Typical Hold Time | 0 Days | 26 Days |
Enterprise Value | $10.61B | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $0.6751, down 3.71% today, with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth with 2026 revenue reaching $9M (20% YoY growth) and strong gross margins of 69.69%, but remains unprofitable with a -125.63% net income margin. Recent positive developments include expanding pediatric footprint, new patent awards, and decreased short interest of 77.4% as of September 15, 2026 (Defense World).
While NUWE demonstrates operational progress and attractive valuation ratios (P/E 0.03, P/S 0.01), the stock faces significant fundamental challenges including persistent losses, negative cash flow, and high debt burden. The mixed analyst coverage (50% Buy, 50% Hold) reflects uncertainty about the company's path to profitability. Investors should weigh the growth potential against substantial execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FormFactor Inc. FormFactor Inc. Common Stock
FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
